Northwest Biothrputcs Inc
(NWBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 200 | 131 | 375 | 231 | 357 |
| Gross Profit | 200 | 131 | 375 | 231 | 357 |
| Operating Expenses | 14,520 | 14,910 | 17,686 | 18,730 | 15,158 |
| Operating Income | -14,320 | -14,779 | -17,311 | -18,499 | -14,801 |
| Interest Expense | 2,621 | 1,826 | 1,602 | 2,488 | 2,080 |
| Other Income | -9,888 | 1,227 | -430 | -7,236 | -2,493 |
| Pre-tax Income | -26,829 | -15,378 | -19,343 | -28,223 | -19,374 |
| Net Income Continuous | -26,829 | -15,378 | -19,343 | -28,223 | -19,374 |
| Net Income | $-26,829 | $-15,378 | $-19,343 | $-28,223 | $-19,374 |
| EPS Basic Total Ops | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -18.22 | -0.01 | -0.01 | -0.02 | -0.02 |
| EBITDA(a) | $-13,455 | $-13,803 | $-16,543 | $-17,204 | $-13,805 |